F4 FundFund
TeamPortfolioRaiseChampionsEssays
Sign in
Investment ThesisInvestment TeamF4 Research BriefSelected PortfolioRecent UpdatesFrequent co-investorsSimilar Firms
Hot Fund
#51 · Emerging 100 · 2026

S32

s32.com · Palo Alto, CA

“Invest in software-driven businesses in technology and healthcare at the frontiers of AI, computational biology, physical AI, cybersecurity, and enterprise software, deliberately avoiding commoditized categories that big tech will give away for free.”

$5M – $10M
Check Size
Leads & Follows
Lead Tendency
$3B
AUM
~1 Month
Timeline
01Investment Thesis

Invest in software-driven businesses in technology and healthcare at the frontiers of AI, computational biology, physical AI, cybersecurity, and enterprise software, deliberately avoiding commoditized categories that big tech will give away for free.

Exclusion Criteria

Avoids commoditized, undifferentiated AI application layers that large incumbents (Google, Microsoft) can replicate and give away for free.

02Investment Team
BM
Bill Maris
General Partner, Founder
AH
Andy Harrison
General Partner, CEO
AC
Andrew Conrad
General Partner
MP
Mike Pellini
General Partner
AC
Alice Cheung
Partner, Talent
BA
Bayan Alizadeh
Partner
DC
Derrick Chow
Partner
KS
Kimberly Shih
Partner, Talent
KF
Kenzo Fong
Partner, Product
WT
Wesley Tillu
Partner
NS
Nick Smith
Chief Investor Relations Officer
NL
Nina Labatt
CFO & COO
03F4 Research Brief

S32 Research

Investment Thesis

S32 (formerly Section 32) is a high-conviction venture firm founded in 2017 by Bill Maris, the former founder and CEO of Google Ventures (GV). The firm invests in software-driven businesses in technology and healthcare "at the frontiers of technology," with an explicit strategy of avoiding commoditized categories where large technology incumbents (Google, Microsoft, etc.) will give capabilities away for free. Instead, S32 concentrates on application-layer and infrastructure bets in artificial intelligence, computational biology, physical AI/robotics, cybersecurity, and enterprise software, where deep technical and scientific expertise creates durable moats.

The firm deliberately limits the number of companies it backs per fund (roughly 20-25 investments per fund) so each portfolio company receives meaningful capital, partner time, and operational support, rather than spreading a large fund thin across many small positions.

Sector Focus

S32's stated focus areas, per its own site and public materials, are:

  • Artificial intelligence (application-layer, avoiding commoditized foundation-model plays)
  • Computational biology and life sciences
  • Physical AI and robotics
  • Infrastructure and developer tooling
  • Cybersecurity
  • Enterprise software

Stage Focus

S32 invests primarily at Series A and Series B, with selective later-stage and seed opportunities (e.g., the 2026 VeYou and Autoscience Institute seed rounds). Public reporting describes typical initial checks of $5M-$10M with substantial reserves for follow-on rounds across a company's lifecycle.

Check Size

Based on public reporting (TechCrunch, 2023): initial checks of roughly $5M-$10M, with meaningful follow-on reserves allocated per position given the fund's concentrated, high-conviction approach.

Lead Tendency

S32 both leads and follows. It led VeYou's 2026 seed round and has historically led or co-led rounds in companies like Coinbase, CrowdStrike, and Databricks. It has also taken participant/follow-on positions alongside other leads, as in the 2026 Autoscience Institute seed (led by General Catalyst) and the Culture Biosciences Series C (led by Northpond Ventures).

Recent Activity

S32 closed Fund V at $525M in October 2023 (oversubscribed), bringing cumulative AUM to roughly $2.3B at the time. In September 2025, the firm held a first close on Fund VI at $413.5M, targeting $600M for the final close — a signal of continued active deployment. Public estimates place total AUM across all six funds at roughly $3B as of 2025-2026. In 2025 the firm made approximately 13 new investments, and as of Q1-Q2 2026 has continued deploying capital, including a March 2026 seed investment in Autoscience Institute (autonomous AI research labs) and a mid-2026 lead seed investment in VeYou (vertical micro-drama streaming).

Portfolio Highlights

S32's portfolio includes some of the most recognizable names in recent venture history: Coinbase, CrowdStrike, Databricks, Scale AI, Cohere, SandboxAQ, Deel, Gusto, Neuralink, Black Forest Labs, Basecamp Research, Snorkel AI, Linear, Whatnot, and Vir Biotechnology. Exits/IPOs include CrowdStrike (2019 IPO), Coinbase (2021 direct listing), and Relay Therapeutics (2020 IPO). The firm reports 10 unicorns, 9 IPOs, and 16 acquisitions across its history. Note that a subset of the firm's most iconic "backed" logos (e.g., Uber, Slack, Nest) predate S32's 2017 founding and were investments made by Bill Maris and team during their earlier tenure at Google Ventures, not S32 fund investments — S32's own site frames these as "notable companies backed prior to S32's formation."

Team

  • Bill Maris — General Partner, Founder. Former CEO of Google Ventures; built a portfolio that included Uber, Nest, and Coinbase before founding S32 in 2017.
  • Andy Harrison — General Partner, CEO. Former executive at Alphabet's X and Verily; two-time startup founder.
  • Andrew Conrad, PhD — General Partner (joined February 2024). Founder and former CEO of Verily Life Sciences (Alphabet's life sciences unit); roughly 30 years of experience spanning biology, data, and AI; previously Chief Scientific Officer at LabCorp.
  • Mike Pellini, MD — General Partner. Former CEO of Foundation Medicine; three decades in personalized medicine.
  • Alice Cheung — Partner, Talent. A decade at Alphabet building teams for Waymo, Loon, Glass, Wing, and Verily; over 1,700 hires.
  • Bayan Alizadeh — Partner. Former investor at Norwest Venture Partners; prior investment banker at Morgan Stanley (worked on Rivian, Nubank, and HashiCorp IPOs).
  • Derrick Chow — Partner. Former investor at CapitalG (Alphabet's growth fund), with exposure to Stripe, UiPath, and Duolingo; prior banker at Morgan Stanley.
  • Kimberly Shih — Partner, Talent. Staffing-industry background; led hiring at Essential; SHRM-CP certified.
  • Kenzo Fong — Partner, Product. Two-time founder and 20+ year product leader; led Android strategy and Google Maps, and founded Uber Eats.
  • Wesley Tillu — Partner. Former investor at In-Q-Tel (the CIA's venture arm); previously led Google Express partnerships; Wharton MBA.
  • Nick Smith — Chief Investor Relations Officer. Former Head of Investor Relations at Foresite Capital.
  • Nina Labatt — CFO & COO. Former COO/GP at Trinity Ventures; Harvard MBA; prior Goldman Sachs experience.

Decision Process

S32 operates as a multi-GP partnership (four General Partners: Maris, Harrison, Conrad, Pellini) supported by a deep bench of investing and operating partners, rather than a solo-GP structure. The firm's talent and product partners (Cheung, Shih, Fong) provide hands-on operational support post-investment, which the firm markets as a core differentiator ("Talent Advantage").

Founder Preferences

S32 favors technical and scientific founders tackling frontier, defensible problems — particularly those building in AI infrastructure, computational biology, robotics/physical AI, cybersecurity, and enterprise software where deep domain expertise creates a moat against big-tech commoditization. The firm's own investment team is heavily weighted toward operators and scientists (ex-Verily, ex-Google/Alphabet, ex-LabCorp, ex-Foundation Medicine), suggesting an affinity for founders with comparable technical depth.

Geographic Focus

Headquartered in Palo Alto, California (Silicon Valley), S32 invests primarily in US-based companies, with its portfolio concentrated in the Bay Area alongside other major US tech hubs.

04Selected Portfolio
AgTech & Agriculture
Ohalo
Biotech & Life Sciences
Neuralink·Basecamp Research·Vir Biotechnology·Relay Therapeutics·Inceptive·NewLimit
E-commerce & Marketplaces
Whatnot
Enterprise Software
Databricks·Cohere·Sandbox AQ·Snorkel AI·Ema·Infleqtion·Phaidra·8090·Autoscience Institute
HR Tech & Future of Work
Gusto
Legal & Regtech
Legora
Media & Entertainment
Black Forest Labs·VeYou
Security & Cybersecurity
CrowdStrike·Endor Labs
Other
Coinbase·Scale AI·Deel·Linear·Culturebiosciences
Open the full portfolio→
05Recent Updates

Fresh signals from public announcements, essays, and portfolio activity.

See full activity (6) →
Led VeYou's seed round, backing the vertical micro-drama streaming app founded by Tommy Harper.
INVESTMENT·deadline.com
JUL 2026
Participated in Autoscience Institute's $14M seed round, led by General Catalyst, to build an automated AI research lab.
INVESTMENT·globenewswire.com
MAR 18, 2026
Participated in Culture Biosciences' Series C round, led by Northpond Ventures, to scale its automated bioprocessing platform.
INVESTMENT·globenewswire.com
DEC 16, 2025
Held a first close on $413.5M for its sixth flagship fund, targeting $600M.
NEW FUND·venturecapitaljournal.com
SEP 2025
Named Verily Life Sciences founder Dr. Andrew Conrad as General Partner.
TEAM CHANGE·prnewswire.com
FEB 22, 2024
06Frequent co-investors
SV
Salesforce Ventures
Both backed 4 of the same companies
Legora, Endor Labs, Black Forest Labs, Cohere
SA
SV Angel
Both backed 4 of the same companies
Gusto, Snorkel AI, Black Forest Labs, Databricks
1V
137 Ventures
Both backed 2 of the same companies
Gusto, Databricks
1C
1789 Capital
Both backed 2 of the same companies
Neuralink, Databricks
A
Accel
Both backed 2 of the same companies
Legora, CrowdStrike
Find the investors for your round→
07Similar Firms
TS
Two Sigma Ventures
$2M – $25M · Seed · Series A
→
RV
Radical Ventures
$1M – $25M · Pre-Seed · Seed
→
WV
Wing Venture Capital
$200K – $20M · Pre-Seed · Seed
→
BV
Bison Ventures
Seed · Series A
→
AS
Air Street Capital
$1M – $300M · Pre-Seed · Seed
→
Quick Reference
Check Size
$5M – $10M
Stages
Seed · Series A · Series B
AUM
$3B
Decision
Partnership · ~1 Month
Warm Intro
Preferred
Involvement
Board Seat
Location
Palo Alto, CA
Sector Focus
Biotech & Life SciencesRobotics & AutomationEnterprise SoftwareDeveloper Tools & InfrastructureSecurity & Cybersecurity
Models
Enterprise SoftwareVertical AI
Technology
AI/MLRoboticsComputational Biology
See all Biotech & Life Sciences investors →See all Robotics & Automation investors →See all Enterprise Software investors →
Visit s32.com ↗

See how S32 matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Focus Areas
Biotech & Life SciencesRobotics & AutomationEnterprise SoftwareDeveloper Tools & InfrastructureSecurity & Cybersecurity

See how S32 matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Is this your firm? Claim your profile
F4 Intelligence Report · Last Researched August 28, 2026F4 Research Engine